{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:44:10Z","timestamp":1790779450406,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R21ES034801"],"award-info":[{"award-number":["R21ES034801"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R21ES034801"],"award-info":[{"award-number":["R21ES034801"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R21ES034801"],"award-info":[{"award-number":["R21ES034801"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R21ES034801"],"award-info":[{"award-number":["R21ES034801"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Per- and polyfluoroalkyl substances (PFAS) may be carcinogenic, and animal studies demonstrate their harmful effects on mammary gland development. Terminal ductal lobular units (TDLUs) are the structures that produce milk following childbirth, and involution of TDLUs normally occurs with aging. Most breast cancers arise from TDLUs, and a greater degree of TDLU involution may be associated with lower breast cancer risk. We estimated associations between PFAS concentrations and TDLU involution in normal breast tissue samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Concentrations of seven PFAS were measured in serum provided by a subset of 263 cancer-free volunteer participants from the Susan G. Komen for the Cure Tissue Bank (KTB) who were postmenopausal, not currently using hormone therapy, and had available TDLU measurements made by a trained pathologist examining H&amp;E stained section of a core biopsy sample of tissue from the outer upper quadrant of a single breast. Bayesian kernel machine regression and quantile-G computation were used to estimate covariate-adjusted associations between the PFAS mixture and measures of TDLU involution (presence of TDLUs, number of observed TDLUs, and median TDLU span) within this population and with stratification on parity and breastfeeding history.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      TDLUs were observed in breast tissue samples of 40.3% (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009106) of the study population, with similar PFAS concentrations between participants with and without observed TDLUs. No strong, statistically significant associations were observed between individual PFAS and presence of observed TDLUs. The overall effect of the PFAS mixture suggested an inverted U-shaped association with odds of observed TDLUs, although this was not statistically significant (\u03b2\u2009=\u20090.03 95% CI -2.75, 2.81;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.98). Among the subgroup of parous women, stratified analyses suggested a positive association between the PFAS mixture and observed TDLUs among those who had ever breastfed, but a slightly negative association among those who had never breastfed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, our analysis does not support meaningful effects of PFAS on TDLU involution, although we note that these findings are not applicable to premenopausal women or to postmenopausal women using hormone therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-025-02103-9","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T11:07:40Z","timestamp":1755515260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Associations of perfluoroalkyl substances (PFAS) with terminal ductal lobular unit involution of the normal breast"],"prefix":"10.1186","volume":"27","author":[{"given":"Katherine W.","family":"Reeves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Oulhote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Grandjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flemming","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"1","key":"2103_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/toxsci\/kfl177","volume":"96","author":"SS White","year":"2007","unstructured":"White SS, Calafat AM, Kuklenyik Z, Villanueva L, Zehr RD, Helfant L, et al. Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci Off J Soc Toxicol. 2007;96(1):133\u201344.","journal-title":"Toxicol Sci Off J Soc Toxicol"},{"key":"2103_CR2","doi-asserted-by":"crossref","unstructured":"White SS, Kato K, Jia LT, Basden BJ, Calafat AM, Hines EP, et al. Effects of perfluorooctanoic acid on mouse mammary gland development and differentiation resulting from cross-foster and restricted gestational exposures. Reprod Toxicol Elmsford N. 2009 ;27(3\u20134):289\u201398.","DOI":"10.1016\/j.reprotox.2008.11.054"},{"issue":"8","key":"2103_CR3","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1289\/ehp.1002741","volume":"119","author":"SS White","year":"2011","unstructured":"White SS, Stanko JP, Kato K, Calafat AM, Hines EP, Fenton SE. Gestational and chronic Low-Dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice. Environ Health Perspect. 2011;119(8):1070\u20136.","journal-title":"Environ Health Perspect"},{"key":"2103_CR4","doi-asserted-by":"crossref","unstructured":"Macon MB, Villanueva LR, Tatum-Gibbs K, Zehr RD, Strynar MJ, Stanko JP, et al. Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetry. Toxicol Sci Off J Soc Toxicol. 2011;122(1):134\u201345.","DOI":"10.1093\/toxsci\/kfr076"},{"key":"2103_CR5","doi-asserted-by":"crossref","unstructured":"Tucker DK, Macon MB, Strynar MJ, Dagnino S, Andersen E, Fenton SE. The mammary gland is a sensitive pubertal target in CD-1 and C57Bl\/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure. Reprod toxicol Elmsford N. 2015 ;54:26\u201336.","DOI":"10.1016\/j.reprotox.2014.12.002"},{"key":"2103_CR6","unstructured":"IARC. Perfluorooctanoic Acid (PFOA). and Perfluorooctanesulfonic Acid (PFOS) [Internet]. [cited 2025 May 28]. Available from: https:\/\/publications.iarc.who.int\/Book-And-Report-Series\/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans\/Perfluorooctanoic-Acid-PFOA-And-Perfluorooctanesulfonic-Acid-PFOS--2025"},{"issue":"11","key":"2103_CR7","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1289\/ehp.10598","volume":"115","author":"AM Calafat","year":"2007","unstructured":"Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. Polyfluoroalkyl chemicals in the U.S. Population: data from the National health and nutrition examination survey (NHANES) 2003\u20132004 and comparisons with NHANES 1999\u20132000. Environ Health Perspect. 2007;115(11):1596\u2013602.","journal-title":"Environ Health Perspect"},{"key":"2103_CR8","doi-asserted-by":"crossref","unstructured":"Mogensen UB, Grandjean P, Nielsen F, Weihe P, Budtz-J\u00f8rgensen E. Breastfeeding as an exposure pathway for perfluorinated alkylates. Environ Sci Technol. 2015 ;49(1):10466\u201373.","DOI":"10.1021\/acs.est.5b02237"},{"key":"2103_CR9","doi-asserted-by":"crossref","unstructured":"P\u00e9rez F, Nadal M, Navarro-Ortega A, F\u00e0brega F, Domingo JL, Barcel\u00f3 D, et al. Accumulation of perfluoroalkyl substances in human tissues. Environ Int. 2013 ;59:354\u201362.","DOI":"10.1016\/j.envint.2013.06.004"},{"issue":"1","key":"2103_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/oemed-2017-104651","volume":"75","author":"Y Li","year":"2018","unstructured":"Li Y, Fletcher T, Mucs D, Scott K, Lindh CH, Tallving P, et al. Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water. Occup Environ Med. 2018;75(1):46\u201351.","journal-title":"Occup Environ Med"},{"key":"2103_CR11","unstructured":"International Agency for Research on Cancer (IARC). Perfluorooctanoic Acid, Tetrafluoroethylene, Dichloromethane, 1,2-Dichloropropane, and 1,3-Propane Sultone [Internet]. 2016. (IARC Monographs Volume 110). Available from: https:\/\/publications.iarc.fr\/547"},{"key":"2103_CR12","doi-asserted-by":"publisher","first-page":"115042","DOI":"10.1016\/j.envres.2022.115042","volume":"219","author":"JS LaKind","year":"2023","unstructured":"LaKind JS, Naiman J, Verner MA, L\u00e9v\u00eaque L, Fenton S. Per- and polyfluoroalkyl substances (PFAS) in breast milk and infant formula: A global issue. Environ Res. 2023;219:115042.","journal-title":"Environ Res"},{"issue":"2","key":"2103_CR13","doi-asserted-by":"publisher","first-page":"25002","DOI":"10.1289\/EHP10359","volume":"130","author":"JS LaKind","year":"2022","unstructured":"LaKind JS, Verner MA, Rogers RD, Goeden H, Naiman DQ, Marchitti SA, et al. Current breast milk PFAS levels in the united States and canada: after all this time, why don\u2019t we know more?? Environ Health Perspect. 2022;130(2):25002.","journal-title":"Environ Health Perspect"},{"key":"2103_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.envres.2016.04.034","volume":"149","author":"ME Romano","year":"2016","unstructured":"Romano ME, Xu Y, Calafat AM, Yolton K, Chen A, Webster GM, et al. Maternal serum perfluoroalkyl substances during pregnancy and duration of breastfeeding. Environ Res. 2016;149:239\u201346.","journal-title":"Environ Res"},{"key":"2103_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.reprotox.2016.07.010","volume":"68","author":"CAG Timmermann","year":"2017","unstructured":"Timmermann CAG, Budtz-J\u00f8rgensen E, Petersen MS, Weihe P, Steuerwald U, Nielsen F, et al. Shorter duration of breastfeeding at elevated exposures to perfluoroalkyl substances. Reprod Toxicol Elmsford N. 2017;68:164\u201370.","journal-title":"Reprod Toxicol Elmsford N"},{"issue":"4","key":"2103_CR16","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/ijc.32357","volume":"146","author":"FR Mancini","year":"2020","unstructured":"Mancini FR, Cano-Sancho G, Gambaretti J, Marchand P, Boutron-Ruault MC, Severi G, et al. Perfluorinated alkylated substances serum concentration and breast cancer risk: evidence from a nested case-control study in the French E3N cohort. Int J Cancer. 2020;146(4):917\u201328.","journal-title":"Int J Cancer"},{"key":"2103_CR17","doi-asserted-by":"crossref","unstructured":"Tsai MS, Chang SH, Kuo WH, Kuo CH, Li SY, Wang MY, et al. A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women. Environ Int. 2020;142:105850.","DOI":"10.1016\/j.envint.2020.105850"},{"issue":"1","key":"2103_CR18","first-page":"56","volume":"13","author":"M Wiels\u00f8e","year":"2017","unstructured":"Wiels\u00f8e M, Kern P, Bonefeld-J\u00f8rgensen EC. Serum levels of environmental pollutants is a risk factor for breast cancer in inuit: a case control study. Environ Health Glob Access Sci Source. 2017;13(1):56.","journal-title":"Environ Health Glob Access Sci Source"},{"issue":"11","key":"2103_CR19","first-page":"1439","volume":"25","author":"EC Bonefeld-J\u00f8rgensen","year":"2014","unstructured":"Bonefeld-J\u00f8rgensen EC, Long M, Fredslund SO, Bossi R, Olsen J. Breast cancer risk after exposure to perfluorinated compounds in Danish women: a case-control study nested in the Danish National birth cohort. Cancer Causes Control CCC. 2014;25(11):1439\u201348.","journal-title":"Cancer Causes Control CCC"},{"issue":"Pt 1","key":"2103_CR20","doi-asserted-by":"publisher","first-page":"131545","DOI":"10.1016\/j.chemosphere.2021.131545","volume":"286","author":"MC Velarde","year":"2022","unstructured":"Velarde MC, Chan AFO, Sajo MEJV, Zakharevich I, Melamed J, Uy GLB, et al. Elevated levels of perfluoroalkyl substances in breast cancer patients within the greater Manila area. Chemosphere. 2022;286(Pt 1):131545.","journal-title":"Chemosphere"},{"issue":"22","key":"2103_CR21","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/jnci\/djj439","volume":"98","author":"TR Milanese","year":"2006","unstructured":"Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, et al. Age-related lobular Involution and risk of breast cancer. J Natl Cancer Inst. 2006;98(22):1600\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"2103_CR22","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/cncr.24167","volume":"115","author":"HJ Baer","year":"2009","unstructured":"Baer HJ, Collins LC, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM. Lobule type and subsequent breast cancer risk: results from the nurses\u2019 health studies. Cancer. 2009;115(7):1404\u201311.","journal-title":"Cancer"},{"issue":"35","key":"2103_CR23","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1200\/JCO.2008.21.5079","volume":"27","author":"KP McKian","year":"2009","unstructured":"McKian KP, Reynolds CA, Visscher DW, Nassar A, Radisky DC, Vierkant RA, et al. Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol. 2009;27(35):5893\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2103_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10549-016-3908-7","volume":"159","author":"JD Figueroa","year":"2016","unstructured":"Figueroa JD, Pfeiffer RM, Brinton LA, Palakal MM, Degnim AC, Radisky D, et al. Standardized measures of lobular Involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study. Breast Cancer Res Treat. 2016;159(1):163\u201372.","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"2103_CR25","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1158\/1055-9965.EPI-20-0723","volume":"29","author":"KH Kensler","year":"2020","unstructured":"Kensler KH, Liu EZF, Wetstein SC, Onken AM, Luffman CI, Baker GM, et al. Automated quantitative measures of terminal duct lobular unit Involution and breast cancer risk. Cancer Epidemiol Prev Biomark. 2020;29(11):2358\u201368.","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"4","key":"2103_CR26","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1158\/1940-6207.CAPR-11-0234","volume":"5","author":"ME Sherman","year":"2012","unstructured":"Sherman ME, Figueroa JD, Henry JE, Clare SE, Rufenbarger C, Storniolo AM, The Susan G. Komen for the cure tissue bank at the IU Simon cancer center: A unique resource for defining the molecular histology of the breast. Cancer Prev Res (Phila Pa). 2012;5(4):528\u201335.","journal-title":"Cancer Prev Res (Phila Pa)"},{"issue":"3","key":"2103_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.chroma.2008.10.113","volume":"1216","author":"LS Haug","year":"2009","unstructured":"Haug LS, Thomsen C, Becher G. A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring. J Chromatogr A. 2009;1216(3):385\u201393.","journal-title":"J Chromatogr A"},{"issue":"1","key":"2103_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1021\/acs.est.3c06499","volume":"58","author":"F Nielsen","year":"2024","unstructured":"Nielsen F, Fischer FC, Leth PM, Grandjean P. Occurrence of major perfluorinated alkylate substances in human blood and target organs. Environ Sci Technol. 2024;58(1):143\u20139.","journal-title":"Environ Sci Technol"},{"key":"2103_CR29","doi-asserted-by":"crossref","unstructured":"Figueroa JD, Pfeiffer RM, Patel DA, Linville L, Brinton LA, Gierach GL et al. Terminal duct lobular unit Involution of the normal breast: implications for breast cancer etiology. J Natl Cancer Inst. 2014;106(10): 1-11 .","DOI":"10.1093\/jnci\/dju286"},{"issue":"12","key":"2103_CR30","first-page":"2765","volume":"23","author":"ZG Khodr","year":"2014","unstructured":"Khodr ZG, Sherman ME, Pfeiffer RM, Gierach GL, Brinton LA, Falk RT, et al. Circulating sex hormones and terminal duct lobular unit Involution of the normal breast. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2014;23(12):2765\u201373.","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"issue":"24","key":"2103_CR31","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879\u201386.","journal-title":"J Natl Cancer Inst"},{"key":"2103_CR32","doi-asserted-by":"crossref","unstructured":"Bobb JF, Valeri L, Claus Henn B, Christiani DC, Wright RO, Mazumdar M et al. Bayesian kernel machine regression for estimating the health effects of multi-pollutant mixtures. Biostatistics. 2015 July 1;16(3):493\u2013508.","DOI":"10.1093\/biostatistics\/kxu058"},{"key":"2103_CR33","doi-asserted-by":"crossref","unstructured":"Niehoff NM, Keil AP, Jones RR, Fan S, Gierach GL, White AJ. Outdoor air pollution and terminal duct lobular Involution of the normal breast. Breast Cancer Res BCR. 2020 ;24(1):100.","DOI":"10.1186\/s13058-020-01339-x"},{"issue":"8","key":"2103_CR34","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/aje\/kwae010","volume":"193","author":"CJ Chang","year":"2024","unstructured":"Chang CJ, Ish JL, Chang VC, Daniel M, Jones RR, White AJ. Exposure to per- and polyfluoroalkyl substances and breast cancer risk: a systematic review and meta-analysis of epidemiologic studies. Am J Epidemiol. 2024;193(8):1182\u201396.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"2103_CR35","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/bcr3170","volume":"14","author":"XR Yang","year":"2012","unstructured":"Yang XR, Figueroa JD, Falk RT, Zhang H, Pfeiffer RM, Hewitt SM, et al. Analysis of terminal duct lobular unit Involution in luminal A and basal breast cancers. Breast Cancer Res BCR. 2012;14(2):R64.","journal-title":"Breast Cancer Res BCR"},{"key":"2103_CR36","doi-asserted-by":"crossref","unstructured":"Vierkant RA, Hartmann LC, Pankratz VS, Anderson SS, Radisky D, Frost MH, et al. Lobular involution: localized phenomenon or field effect? Breast Cancer Res Treat. 2009;117(1):193\u20136.","DOI":"10.1007\/s10549-008-0082-6"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02103-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-025-02103-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02103-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T01:44:44Z","timestamp":1757468684000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-025-02103-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2103"],"URL":"https:\/\/doi.org\/10.1186\/s13058-025-02103-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6829962\/v1","asserted-by":"object"}]},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All Komen Tissue Bank participants provided written informed consent at the time of donation. Human subjects approval for the Komen Tissue Bank was provided by the Institutional Review Board at Indiana University. The present research utilized fully deidentified data and previously collected biospecimens and thus was determined to not qualify as human subjects research by the Institutional Review Board at the University of Massachusetts Amherst.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PG has served as a health expert for PFAS-exposed populations in legal cases. KR, YO, and FN declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}